Elizabeth Neubauer, DPM
Podiatrist · Lafayette, CONPI 1548790611
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (49.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Stryker at 40.7% of the total. Reporting peaked in 2021 at $2,673 and has fallen 78.1% since, to $585 in 2025.
Across 48 payments — averaging $140.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Medwest Associates$2K
- Gemini Medical LLC$947
- Johnson & Johnson$211
- Smith+Nephew$171
- Acumed LLC$133
- plus $93 from 2 others
What the payments were for
- Travel & lodging$4957%
- Food & beverage$2,88043%
- Education$3,34750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 32 | $2,737 |
| Medwest Associates | 3 | $2,431 |
| Gemini Medical LLC | 1 | $947 |
| Johnson & Johnson | 5 | $211 |
| Smith+Nephew | 4 | $171 |
| Acumed LLC | 1 | $133 |
| Zimmer Biomet | 1 | $66 |
| Orthofix Medical, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANCHORAGE$719
- HOFFMANN$599
- STAR$549
- VARIAX$288
- ASNIS$163
- VALOR$151
- N/A$143
- GRAFIX PL$139
- CARTIVA$133
- ACUMED$133
- INnate Implant$133
- InFrame Implant$133
- ORTHOLOC 2 LAPIFUSE$106
How this compares
$6,722 in reported general payments places this provider in the 75th percentile of 70 podiatrist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 37 | $496 |
| Oxycodone Hcl | 31 | $221 |
| Gabapentin | 17 | $178 |
| Celecoxib | 11 | $130 |
| Tramadol Hcl | 15 | $72 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Lafayette
- Daniel HatchGreeley$7.2M
- Jeremy ChristensenCastle Rock$87K
- Amber KavanaghDenver$20K
- Kenneth MorganDenver$20K
- George ConnerColorado Springs$16K
- Andrea BatraDenver$12K
- Kevin BlueParker$11K
- Christopher JetterCortez$10K
- Varun ChopraDenver$10K
- Erica SeyboldCentennial$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.